Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diamandis

Showing results (131-140 of 1,134) with videos related to

Pageof 114
Sort By:
Clinical Chemistry and Laboratory Medicine|October 8, 2015
The side effects of translational omics: overtesting, overdiagnosis, overtreatmentEleftherios P Diamandis, Michelle Li
Clinical Chemistry and Laboratory Medicine|September 22, 2015
Glypican-1 as a highly sensitive and specific pancreatic cancer biomarkerEleftherios P Diamandis, Mario Plebani
Molecular Oncology|April 23, 2009
Androgens act synergistically to enhance estrogen-induced upregulation of human tissue kallikreins 10, 11, and 14 in breast cancer cells via a membrane bound androgen receptorMiltiadis Paliouras, Eleftherios P Diamandis
Clinical Chemistry|August 9, 2008
Utility of kallikrein-related peptidases (KLKs) as cancer biomarkersNashmil Emami, Eleftherios P Diamandis
Biological Chemistry|June 28, 2006
The kallikrein world: an update on the human tissue kallikreinsMiltiadis Paliouras, Eleftherios P Diamandis
Clinical Chemistry|May 30, 2009
The search for new prostate cancer biomarkers continuesMaria Pavlou, Eleftherios P Diamandis
Clinical Biochemistry|April 25, 2017
The emerging landscape of scientific publishingClare Fiala, Eleftherios P Diamandis
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 3, 2008
Intracellular signaling pathways regulate hormone-dependent kallikrein gene expressionMiltiadis Paliouras, Eleftherios P Diamandis
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
Detection of the TP53 tumour suppressor gene product and p53 auto-antibodies in the ascites of women with ovarian cancerK Angelopoulou, E P Diamandis
The Journal of Applied Laboratory Medicine|October 23, 2019
Theranos: Almost Complete Absence of Laboratory Medicine InputClare Fiala, Eleftherios P Diamandis
Pageof 114

Showing results (131-140 of 1,134) with videos related to

Sort By:
Pageof 114
Clinical Chemistry and Laboratory Medicine|October 8, 2015
The side effects of translational omics: overtesting, overdiagnosis, overtreatmentEleftherios P Diamandis, Michelle Li
Clinical Chemistry and Laboratory Medicine|September 22, 2015
Glypican-1 as a highly sensitive and specific pancreatic cancer biomarkerEleftherios P Diamandis, Mario Plebani
Molecular Oncology|April 23, 2009
Androgens act synergistically to enhance estrogen-induced upregulation of human tissue kallikreins 10, 11, and 14 in breast cancer cells via a membrane bound androgen receptorMiltiadis Paliouras, Eleftherios P Diamandis
Clinical Chemistry|August 9, 2008
Utility of kallikrein-related peptidases (KLKs) as cancer biomarkersNashmil Emami, Eleftherios P Diamandis
Biological Chemistry|June 28, 2006
The kallikrein world: an update on the human tissue kallikreinsMiltiadis Paliouras, Eleftherios P Diamandis
Clinical Chemistry|May 30, 2009
The search for new prostate cancer biomarkers continuesMaria Pavlou, Eleftherios P Diamandis
Clinical Biochemistry|April 25, 2017
The emerging landscape of scientific publishingClare Fiala, Eleftherios P Diamandis
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 3, 2008
Intracellular signaling pathways regulate hormone-dependent kallikrein gene expressionMiltiadis Paliouras, Eleftherios P Diamandis
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
Detection of the TP53 tumour suppressor gene product and p53 auto-antibodies in the ascites of women with ovarian cancerK Angelopoulou, E P Diamandis
The Journal of Applied Laboratory Medicine|October 23, 2019
Theranos: Almost Complete Absence of Laboratory Medicine InputClare Fiala, Eleftherios P Diamandis
Pageof 114